:::

詳目顯示

回上一頁
題名:慢性C型肝炎病患接受干擾素與Ribavirin合併治療之症狀困擾、憂鬱與生活品質之探討
書刊名:護理暨健康照護研究
作者:黃俐綾宋琇鈺 引用關係劉麗芳張彩秀 引用關係
作者(外文):Huang, Li-lingSung, Hsiu-yuLiu, Li-fangChang, Tsai-hsiu
出版日期:2010
卷期:6:3
頁次:頁183-190
主題關鍵詞:慢性C型肝炎困擾憂鬱生活品質Chronic hepatitis CDistressDepressionQuality of life
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:81
期刊論文
1.Glacken, M., Coates, V., Kernohan, G.,、Hegarty, J.(2003)。The experience of fatigue for people living with hepatitis C。Journal of Clinical Nursing,12(2),244-253。  new window
2.李燕鳴(20040200)。基層醫療中C型肝炎之諮詢與防制。基層醫學,19(2),41-46。  延伸查詢new window
3.許景盛、高嘉宏(20070900)。病毒性肝炎與代謝症候群。臺灣醫學,11(5),518-529。  延伸查詢new window
4.曾光毅、曾嵩智、林佩璇(20040300)。現階段C型肝炎的預防與治療。基層醫學,19(3),61-66。  延伸查詢new window
5.李昱、楊明仁、賴德仁、邱念睦、周騰達(20001100)。Development of the Taiwanese Depression Questionnaire。長庚醫學,23(11),688-694。  延伸查詢new window
6.林聰蓉、廖麗瑛、王鐘貴(2007)。慢性C型肝炎治療的新展望。北市醫學雜誌,4(9),873-879。  延伸查詢new window
7.張淑娟、楊勝舜(2006)。慢性C型肝炎患者接受干擾素合併Ribavirin治療的生活經驗。實證護理,2(1),34-42。new window  延伸查詢new window
8.莊萬龍、余明隆(2007)。慢性C型肝炎之治療。台灣醫學,11(5),507-517。  延伸查詢new window
9.Bonkovsky, H. L., Snow, K. K., Malet, P. F., Back-Madruga, C.,Fontana, R. J., Sterling, R. K., et al.(2007)。Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis。Journal of Hepatology,46(3),420-431。  new window
10.Chang, S. C., Ko, W. S., Wu, S. S., Peng, C. Y.,、Yang, S. S.(2008)。Factors associated with quality of life in chronic hepatitis C patients who received interferon plus ribavirin therapy。Journal of Formosan Medical Association,107(6),454-462。  new window
11.Iosue, K.(2002)。Chronic hepatitis C: Latest treatment options。The Nurse Practitioner,27(4),32-49。  new window
12.Lieb, K., Engelbrecht, M. A., Gut, O., Feibich, B. L., Bauer, J.,Janssen, G., et al.(2006)。Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα):Results from a prospective study。European Psychiatry,21(3),204-210。  new window
13.Sherman, M., Cohen, L., Cooper, M. A., Elkashab, M., Feinman,V., Fletcher, D., et al.(2006)。Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin。Canadian Journal of Gastroenteroloy,20(8),519-520。  new window
14.Strader, D. B., Wright, T., Thomas, D. L.,、Seeff, L. B.(2004)。Diagnosis, management, and treatment of hepatitis C。Hepatology,39(4),1147-1171。  new window
15.Sulkowski, M. S.(2005)。Management of the hematologic complications of hepatitis C therapy。Hepatology,9(4),601-616。  new window
16.The Global Burden of Hepatitis C Working Group.(2004)。Global burden of disease (GBD) for hepatitis C。Journal of Clinical Pharmacology,44(1),20-29。  new window
17.Dan, A. A., Martin, L. M., Crone, C., Ong, J. P., Farmer, D. W., Wise, T., et al.(2006)。Depression, anemia and health related quality of life in chronic hepatitis C。Journal of Hepatology,44(3),491-498。  new window
18.Ferenci, P., Formann, E., Laferl, H., Gschwantler, M., Hackl, F., Brunner, H., et al.(2006)。Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naive patients with chronic hepatitis C genotype 1 infection。Journal of Hepatology,44(2),275-285。  new window
圖書
1.姚開屏(2005)。台灣簡明版世界衛生組織生活品質問卷之發展及使用手冊。台北:世界衛生組織生活品質問卷台灣簡明版發展小組。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE